指南与共识呼吸道感染

成人医院获得性肺炎与呼吸机相关性肺炎诊治中国指南(2026版)制定方案

Chinese guideline for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2026 edition): protocol
RSS 订阅 · 指南共识 · 肺炎 · 2026-06-29

本文为《成人医院获得性肺炎与呼吸机相关性肺炎诊治中国指南(2026版)》的制定方案。鉴于2018版发布后我国HAP/VAP领域在预防理念、病原谱与耐药变迁、快速分子诊断、新型抗菌药物及人工智能应用等方面变化显著,亟需基于最新本土数据更新。指南由中华医学会呼吸病学分会感染学组与中国医师协会呼吸医师分会呼吸感染工作组联合发起。

要点

  • 指南涵盖预防、诊断、抗菌治疗和其他治疗四大主题。
  • 将系统检索中英文数据库,按2011牛津证据等级评价方法学质量。
  • 最终指南按RIGHT声明撰写,计划于2026年发布。

核心结论

  • 需基于最新本土流行病学与循证数据更新2018版HAP/VAP诊治指南,以提升我国HAP/VAP诊治规范化水平并减轻疾病负担。

研究设计与样本

  • 本文件为指南制定方案,由中华医学会呼吸病学分会感染学组与中国医师协会呼吸医师分会呼吸感染工作组联合发起。
  • 指南已在国际实践指南注册平台注册(PREPARE-2026CN795)。
  • 工作组设指导委员会、写作专家组、秘书处及外部评审组,覆盖预防、诊断、抗菌治疗和其他治疗四大主题。
  • 将系统检索中英文数据库纳入相关研究证据,按2011牛津循证医学中心证据等级评价方法学质量。
  • 通过专家讨论与共识会议形成推荐意见,最终指南按RIGHT声明撰写,计划2026年发布。

主要发现

  • 2018版发布以来,我国HAP/VAP诊治领域在预防理念与措施、病原谱与耐药模式、快速分子诊断技术应用、新型抗菌药物及人工智能临床需求等方面发生显著变化。

局限性

  • 本文仅为指南制定方案,尚未提供具体推荐条款与循证数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Zhonghua Jie He He Hu Xi Za Zhi. 2026 Jul 12;49(7):723-727. doi: 10.3760/cma.j.cn112147-20260427-00237. ABSTRACT This document serves as the protocol for the development of the Chinese Guideline for the Diagnosis and Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Adults (2026 Edition) . Since the publication of the previous edition in 2018, the field of HAP/VAP diagnosis and treatment in China has undergone substantial changes, including updates in prevention concepts and measures, evolution of the pathogen spectrum and antimicrobial resistance patterns, widespread adoption of rapid molecular diagnostic technologies, the advent of novel antimicrobial agents, and growing demand for artificial intelligence applications in clinical practice; an update based on the latest local epidemiologic and evidence-based data is therefore urgently needed. This guideline is jointly initiated by the Infection Group of the Chinese Thoracic Society and the Respiratory Infection Group of the Chinese Association of Chest Physicians, and has been registered with the International Practice Guideline Registry(PREPARE-2026CN795). The guideline working group comprises a steering committee, a writing expert group, a secretariat, and an external review group, covering four major topics: prevention, diagnosis, antimicrobial therapy, and other treatments. Through systematic searches of Chinese and English databases, relevant research evidence will be appropriately included; methodologic quality will be appraised according to the 2011 Oxford Centre for Evidence-Based Medicine Levels of Evidence, and recommendations will be formulated through expert discussions and consensus meetings. The final guideline will be drafted in accordance with the RIGHT (Reporting Items for practice Guidelines in HealThcare) statement and is scheduled for publication in 2026, aiming to enhance the standardization of HAP/VAP diagnosis and treatment in China and to reduce the associated disease burden. PMID: 42373446 | DOI: 10.3760/cma.j.cn112147-20260427-00237

来源:指南共识 · 肺炎,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 肺炎:Chinese guideline for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2026 edition): protocol

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。